1. Tait, D L, Obermiller, P S, Jensen, R A, Holt, J T. . Ovarian cancer gene therapy. In Hematology/oncology clinics of North America, 12, 539-52. doi:. https://pubmed.ncbi.nlm.nih.gov/9684097/
2. Li, Yaping, Huang, Baohua, Yang, Hua, Shu, Wei, Chen, Ming. 2020. Latexin deficiency in mice up-regulates inflammation and aggravates colitis through HECTD1/Rps3/NF-κB pathway. In Scientific reports, 10, 9868. doi:10.1038/s41598-020-66789-x. https://pubmed.ncbi.nlm.nih.gov/32555320/
3. He, Guozhang, Ni, Yuanting, Hua, Rong, Liang, Hong, Chen, Ming. 2024. Latexin deficiency limits foam cell formation and ameliorates atherosclerosis by promoting macrophage phenotype differentiation. In Cell death & disease, 15, 754. doi:10.1038/s41419-024-07141-3. https://pubmed.ncbi.nlm.nih.gov/39424784/
4. Muthusamy, Viswanathan, Premi, Sanjay, Soper, Cara, Platt, James, Bosenberg, Marcus. 2013. The hematopoietic stem cell regulatory gene latexin has tumor-suppressive properties in malignant melanoma. In The Journal of investigative dermatology, 133, 1827-33. doi:10.1038/jid.2013.48. https://pubmed.ncbi.nlm.nih.gov/23364479/
5. Cui, Xiaojing, Zhang, Cuiping, Wang, Fang, Tong, Sheng, Liang, Ying. 2023. Latexin regulates sex dimorphism in hematopoiesis via gender-specific differential expression of microRNA 98-3p and thrombospondin 1. In Cell reports, 42, 112274. doi:10.1016/j.celrep.2023.112274. https://pubmed.ncbi.nlm.nih.gov/36933218/
6. Seed, Robert I, Taurozzi, Alberto J, Wilcock, Daniel J, Maitland, Norman J, Collins, Anne T. 2019. The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy. In Scientific reports, 9, 5120. doi:10.1038/s41598-019-41379-8. https://pubmed.ncbi.nlm.nih.gov/30914656/
智鼠故事 
